INTRODUCTION {#S1}
============

Polycystic kidney disease (PKD) is a family of hereditary disorders characterized by the formation and progressive expansion of numerous fluid-filled cysts that cause massively enlarged kidneys ([@R1]). Renal cysts are benign neoplasms that ultimately cause renal insufficiency through extensive nephron loss and replacement of normal parenchyma with fibrosis ([@R2]). Autosomal dominant PKD (ADPKD) is the most common inherited renal disorder with a frequency of 1:500 individuals and accounts for 7--9% of patients on renal replacement therapy. ADPKD is caused by mutations in *PKD1* or *PKD2*, genes that encode polycystin-1 (PC1) and polycystin-2 (PC2), respectively ([@R3]--[@R6]). Autosomal recessive PKD (ARPKD) is less common (\~1:20,000 births) and is caused by mutations in *PKHD1*, a gene that encodes fibrocystin. ARPKD is characterized by rapid disease progression, often leading to renal failure within the first year of life. Several signaling pathways, including those regulated by cAMP, growth factors, B-Raf/MEK/ERK, mammalian Target Of Rapamycin (mTOR), integrins, and Akt have been implicated in aberrant cell proliferation and the relentless expansion of PKD cysts ([@R7]--[@R16]).

In addition to intrinsic defects in PKD cells, factors secreted into the extracellular environment may also contribute to cyst growth and development of interstitial fibrosis. We and others have shown that mRNA levels of genes involved in tissue remodeling and extracellular matrix (ECM) production are highly elevated in cystic cells compared to normal renal cells ([@R12], [@R17]). In fact, periostin was one of the most highly differentially expressed genes in human ADPKD cells compared to normal tubule cells ([@R12]). Periostin is a secreted protein that binds to components of the ECM, including type I collagen and fibronectin, and has been implicated in collagen fibrillogenesis ([@R18]--[@R20]). Periostin, as well as other "matricellular" proteins, transmits signals from the ECM to the cell by binding to cell surface integrins, leading to changes in cell adhesion, migration, proliferation, survival and tissue angiogenesis ([@R21]--[@R26]). While periostin is expressed in several tissues during embryonic development ([@R27], [@R28]), its expression in adults is restricted to collagen-rich tissues and can be upregulated by mechanical stress ([@R29]--[@R31]). Periostin has also been found to be elevated in a variety of cancers, including breast, lung, and colon, where it promotes cell proliferation and survival ([@R21], [@R22], [@R25], [@R32]--[@R36]).

In ADPKD, periostin is secreted by cyst-lining cells and accumulates within the ECM adjacent to cysts ([@R12]). Periostin binds α~V~β~3~ and α~V~β~5~ integrins and stimulates integrin-linked kinase (ILK), leading to an acceleration of cell proliferation and *in vitro* cyst growth of ADPKD cells within a collagen matrix. By contrast, periostin does not stimulate the proliferation of normal renal cells, suggesting that periostin is a novel autocrine mitogen secreted by cystic cells ([@R12]). In this study, we show that upregulation of periostin expression is not limited to ADPKD, but rather is a common feature of inherited renal cystic epithelia, regardless of the underlying genetic defect. To determine if periostin contributes to PKD progression, we knocked out periostin (*Postn*) expression in *pcy/pcy* mice, a well characterized model orthologous to human nephronophthisis type three, a recessive form of PKD that typically causes renal failure in children and adolescents ([@R37], [@R38]). In *pcy/pcy* mice, cystic kidneys enlarge to several times normal size and are associated with extensive renal interstitial fibrosis by 18 weeks of age and the development of azotemia ([@R37]). Previously, we monitored PKD progression in a *pcy/pcy* mouse by measuring kidney volume by magnetic resonance imaging. Kidney volume increased exponentially up to 20 weeks of age, after which there was a plateau as renal parenchyma was replaced with fibrosis ([@R39]). In this study, we determined if loss of *Postn* expression reduced kidney weight, cystic index, cell proliferation and fibrosis in 20-week old *pcy/pcy* mice and extended their survival. The results indicate that periostin and its associated signaling pathways may be viable targets for therapy in PKD.

RESULTS {#S2}
=======

Periostin expression in pcy/pcy kidneys {#S3}
---------------------------------------

Periostin (*Postn*) mRNA is highly overexpressed in human ADPKD cyst epithelial cells compared to normal human kidney cells ([@R12]). Similarly, we found that *Postn* is overexpressed in ARPKD and several animal models of cystic disease ([Table 1](#T1){ref-type="table"}), suggesting that aberrant periostin expression is a general feature of PKD, regardless of the underlying genetic mutation.

To determine if periostin was increased in cystic kidneys of *pcy/pcy* mice, we compared *Postn* expression to WT mice at 1, 10 and 20 weeks. Kidney volume of *pcy/pcy* mice was elevated at 1 week and continued to increase to 20 weeks ([Fig. 1a](#F1){ref-type="fig"}), as described previously ([@R39]). By contrast, body weight of *pcy/pcy* mice was reduced compared to WT mice ([Fig. 1b](#F1){ref-type="fig"}). At 20 weeks, periostin mRNA ([Fig. 1c](#F1){ref-type="fig"}) and protein ([Fig. 1d](#F1){ref-type="fig"}, [Supplemental Figure S1](#SD1){ref-type="supplementary-material"}) were elevated in *pcy/pcy* kidneys compared to age-matched WT kidneys, confirming that periostin is overexpressed in this model of slowly progressive renal cystic disease.

Effects of periostin on body and kidney mass and renal cystic disease {#S4}
---------------------------------------------------------------------

Periostin knockout mice have been reported previously ([@R40]). Consistent with this report, sex-matched *Postn^−/−^* mice were similar in general appearance to WT (*Postn^+/+^)* littermates (not shown). Also as reported, 20-week old *Postn^−/−^* mice exhibited a moderate reduction in body weight compared to WT littermates (36.8 ± 1.1 g for WT *vs.* 31.6 ± 0.9 g for the *Postn^−/−^*, P \< 0.005) ([Fig. 2a](#F2){ref-type="fig"}). However, there was no difference in total kidney weight (both kidneys) between *Postn^−/−^* and WT mice when corrected for body weight (%BW) ([Fig. 2b](#F2){ref-type="fig"}).

To examine the effects of periostin on cystic disease, *Postn*^−/−^ mice were bred with *pcy/pcy* mice to generate *pcy/pcy:Postn*^−/−^ mice. As expected, loss of periostin expression, confirmed by immunoblot analysis ([Supplemental Figure S1](#SD1){ref-type="supplementary-material"}), caused a reduction in body weight of *pcy/pcy: Postn^−/−^* mice from 26.3 ± 0.7 to 22.2 ± 0.7 g (P \< 0.01) at 20 weeks of age, similar to the effect in WT mice ([Fig. 2a, c](#F2){ref-type="fig"}). However, in contrast to the lack of an effect of *Postn* knockout on kidney mass in normal mice, *pcy/pcy:Postn^−/−^* mice showed a dramatic decrease in KW/BW (5.9 ± 0.5 *vs*. 3.9 ± 0.4 %, P \< 0.001) compared to *pcy/pcy:Postn^+/+^* mice ([Fig. 2d](#F2){ref-type="fig"}). To understand the ameliorating effects of periostin loss on kidney enlargement, kidneys from *pcy/pcy:Postn^−/−^* were sectioned for microscopic examination. Compared to *pcy/pcy:Postn^+/+^* mice, kidneys from *pcy/pcy:Postn^−/−^* mice showed a significant reduction in cystic area ([Fig. 3a](#F3){ref-type="fig"}). Measurements of cyst surface area in three non-overlapping representative kidney sections demonstrated decreased cystic area in the *Postn* knockout mice from 42.5 ± 2.4 to 21.8 ± 4.2%; P \< 0.005 ([Fig. 3b](#F3){ref-type="fig"}). There was also a 28% reduction in the number of cysts per section ([Fig. 3c](#F3){ref-type="fig"}). Thus, loss of periostin expression results in a significant reduction in pathologic enlargement of *pcy/pcy* kidneys by reducing cyst number and total cystic area.

Effect of periostin on cell proliferation in pcy/pcy kidneys {#S5}
------------------------------------------------------------

Previously, periostin was shown to stimulate ADPKD cell proliferation through binding α~V~-integrins and activation of ILK ([@R12]), suggesting that periostin provides a proliferative signal that contributes to renal cyst expansion. To test this, we measured the number of proliferating cells in 20 week-old kidneys of *pcy/pcy:Postn^−/−^* mice compared to *pcy/pcy:Postn^+/+^* mice by immunohistochemistry using antibodies to proliferating cell nuclear antigen (PCNA) and Ki-67, nuclear markers for cell proliferation. There were visibly fewer PCNA-positive cells (brown precipitate, arrows) in *pcy/pcy: Postn^−/−^* compared to *pcy/pcy: Postn^+/+^* kidney sections ([Fig. 4a, b](#F4){ref-type="fig"}), as confirmed by manual counting positive cells in these sections ([Fig. 4e](#F4){ref-type="fig"}). In contrast, *Postn* knockout in mice without renal cystic disease did not affect the number of PCNA-positive cells in the kidneys ([Fig. 4c--e](#F4){ref-type="fig"}).

To confirm the PCNA results, we measured the number of Ki-67 positive cells by immunofluorescence, normalizing for total cell number using the nuclear stain DAPI. As with PCNA staining, kidney sections from *pcy/pcy: Postn^−/−^* mice (N = 3) had significantly fewer Ki-67 positive cells than those from *pcy/pcy: Postn^+/+^* mice (2.6 ± 0.2 *vs*. 0.6 ± 0.2 per field, P \< 0.001, [Fig. 4f](#F4){ref-type="fig"}). Taken together, these data support the hypothesis that periostin expression is an important contributor to the proliferation of cystic epithelial cells and promotes cyst expansion and kidney enlargement in *pcy/pcy* mice.

To examine the mechanism by which periostin contributes to cell proliferation, we examined effects of *Postn* knockout on the mTOR pathway. This signaling pathway has been implicated in cyst epithelial cell proliferation, and there is increased phosphorylation of downstream targets of mTOR pathway, S6K and S6, in cystic kidneys of human ADPKD, ARPKD and PKD animals, including the *pcy/pcy* mice ([@R8], [@R41]--[@R43]). The mTOR pathway is also known to be a downstream target of ILK ([@R44]), which we have shown to be activated by periostin ([@R12]). To determine whether *Postn* knockout affects mTOR signaling in *pcy/pcy* mice, kidney lysates were prepared and amounts of phosphorylated S6 (pS6) were determined by immunoblot analysis ([Fig. 5](#F5){ref-type="fig"}). The level of pS6, normalized to total S6 (pS6/S6), was significantly decreased (0.35 ± 0.02 *vs*. 1.13 ± 0.12, N = 3, P \< 0.05), despite an increase in total S6 in *pcy/pcy: Postn^−/−^* kidneys. There was also a 26% decrease in band intensity for pS6K (P \< 0.05, data not shown) in *pcy/pcy: Postn^−/−^* kidneys. These data suggest that diminished activity of the mTOR pathway contributes to the reduction in cell proliferation and cystic area in kidneys of *pcy/pcy:Postn^−/−^* mice.

Influence of periostin on renal interstitial fibrosis in pcy/pcy mice {#S6}
---------------------------------------------------------------------

Periostin directly interacts with components of the ECM, including collagen and fibronectin, and promotes collagen cross-linking and fibrogenesis ([@R18]--[@R20]). In addition to modulating biomechanical properties of tissues, periostin enhances pro-fibrotic TGF-β signaling and can induce fibrosis ([@R45], [@R46]). To assess the role of periostin in renal interstitial fibrosis in *pcy/pcy* mice, kidney sections were stained with Masson trichrome. There was intense blue staining of the collagen deposition adjacent to cysts of 20-week old *pcy/pcy* kidneys and this staining was significantly reduced in *pcy/pcy:Postn^−/−^* kidneys ([Fig. 6](#F6){ref-type="fig"}). Under a polarizing light, picrosirius red, which specifically stains collagen types 1 and III, visualizes pathogenic fibrils within the interstitium. We found that % area of collagen fibrils within the renal interstitium was reduced in *pcy/pcy* mice lacking periostin compared to *pcy/pcy:Postn^+/+^* mice; however, this difference did not reach statistical significance (P = 0.06) ([Fig. 7](#F7){ref-type="fig"}). Nevertheless, in conjunction with the results from analysis of trichrome staining ([Fig. 6](#F6){ref-type="fig"}), these results suggest that periostin directly or indirectly contributes to renal fibrosis in this model of PKD.

Effect of periostin on renal function and survival of pcy/pcy mice {#S7}
------------------------------------------------------------------

Since *Postn* knockout significantly reduced cystic index, fibrosis and kidney enlargement in *pcy/pcy* mice, we determined if the loss of *Postn* expression improved renal function. As expected, 20 week-old *pcy/pcy: Postn^+/+^* mice had elevated blood urea nitrogen (BUN: 48.7 ± 7.2 mg/dl; normal range is 8--33 mg/dl) with four of the six mice with values above 40 mg/dl ([Fig. 8](#F8){ref-type="fig"}). By contrast, *pcy/pcy: Postn^−/−^* mice had a BUN of 31.3 ± 5.7 mg/dl, P \< 0.05, demonstrating that gene knockout of *Postn* significantly improved renal function in *pcy/pcy* mice.

To further examine the effect of *Postn* expression on disease severity, we compared the kidney morphology of sex-matched *pcy/pcy: Postn^+/+^*, *pcy/pcy: Postn^+/−^* and *pcy/pcy: Postn^−/−^* litermates at 20 weeks. Loss of one allele (*Postn^+/−^*) caused a small reduction in kidney weight and decreased cystic area from 47% to 34%; whereas, complete loss of *Postn* expression reduced kidney weight (%BW) from 5.9 to 2.7% and decreased cystic area to 9%. Previously, periostin expression in *Postn^+/−^* newborn mice was found to be \~30 to 50% of the normal level ([@R40]). These data suggest that there was a gene dosage effect of periostin on PKD progression in *pcy/pcy* mice.

Next, we compared the lifespan of *pcy/pcy: Postn^+/+^*, *pcy/pcy: Postn^+/−^* and *pcy/pcy: Postn^−/−^* mice that were fed a standard diet *ad libitum* and monitored daily until natural death. Periostin expressing *pcy/pcy* mice lived to 38.1 ± 2.0 weeks, slightly longer than the 30--36 week time span previously reported ([@R37]). Interestingly, mice heterozygous at the periostin locus (*pcy/pcy: Postn^+/−^*) survived to 44.4 ± 2.4 weeks ([Fig. 9b, c](#F9){ref-type="fig"}). Complete knockout of periostin (*pcy/pcy: Postn^−/−^*) resulted in a significant increase in survival to 51.4 ± 4.2 weeks with all the mice in this group living longer than the mean age of death for the *pcy/pcy:Postn^+/+^* mice (38.1 ± 2.0 weeks). Taken together, these studies demonstrate that renal expression of periostin in *pcy/pcy* mice accelerates disease progression by stimulating cyst epithelial cell proliferation and interstitial fibrosis, thereby contributing to a decline in renal function and death.

DISCUSSION {#S8}
==========

Periostin is a member of the matricellular proteins that also includes thrombospondins, osteopontin, βig-H3, SPARC and connective tissue growth factors. These small molecules are secreted into the ECM, where they modulate matrix accumulation and collagen fibrillogenesis and bind cell surface integrins to regulate a variety of cell functions, including cell adhesion, migration, proliferation and survival ([@R18], [@R21], [@R22], [@R24], [@R25], [@R32]). In this study, we found that periostin contributes importantly to renal cyst enlargement and disease progression in *pcy/pcy* mice. Global knockout of *Postn* in *pcy/pcy* mice 1) caused a significant reduction in the KW/BW ratio, 2) decreased renal mTOR activity, 3) reduced the number of proliferating cells, cyst number and cystic area, 4) decreased renal interstitial fibrosis, 5) preserved renal function, and 6) significantly extended the lifespan of the mice.

Our data suggest that periostin is an important contributing factor for the progression of PKD by promoting the proliferation of cystic cells *in vivo*. We have previously shown that periostin activates ILK, which promotes human ADPKD cell proliferation ([@R12]). Here, we show that *Postn* loss in the *pcy/pcy* mouse model diminished the activity of mTOR, a signaling pathway implicated in the aberrant proliferation of renal epithelial cells and formation of cysts in human ADPKD, ARPKD and animal models of PKD, including the *pcy/pcy* mouse ([@R8], [@R41]--[@R43]). Moreover, mTOR is known to be activated downstream of ILK, via AKT-dependent phosphorylation of tuberin (TSC2) ([@R44]). These results suggest that a periostin-ILK-AKT-mTOR signaling axis may be an important mechanism underlying periostin-stimulated cyst cell proliferation.

Periostin is one of the most highly over-expressed genes in human ADPKD cells compared to normal human kidney epithelial cells ([@R12]). In this study, we show that periostin is also highly overexpressed in human ARPKD and multiple mouse models of renal cystic disease. This finding implies that periostin overexpression may be a general feature of cystic kidney disease. The mechanism responsible for aberrant periostin expression in cystic disease remains unclear; however, its expression may reflect its role in development and repair. Periostin is highly expressed in the nephrogenic zone, an active site of cell proliferation and vascularization during renal development ([@R47]); however, it is not normally expressed in adult kidney. It is possible that persistent expression of periostin has a pro-proliferative effect on these immature developing tubule cells, contributing to cyst growth. Indeed, ADPKD cystic epithelial cells have been characterized as being arrested at a stage of incomplete differentiation ([@R48]). Periostin has also been shown to be elevated by mechanical stress ([@R20]). It is possible that fluid accumulation by active fluid secretion into the cyst lumen increases internal pressure to elicit a stress response in mural epithelial cells, leading to periostin expression.

Periostin also plays an important role in tissue repair, including repair after acute myocardial infarction and cardiac fibrosis ([@R49]--[@R52]). Since renal cyst expansion results in chronic injury ([@R53]), aberrant periostin expression may be involved in a futile repair mechanism ([@R9]) that contributes to cell proliferation, cyst expansion and ultimately renal fibrosis.

Matricellular proteins, such as periostin, are being considered as potential therapeutic targets to prevent fibrosis. Currently, the role of periostin in other chronic kidney diseases remains unclear. Periostin expression appeared *de novo* within the distal tubules after 5/6 nephrectomy ([@R54]) and, following glomerular injury, increased expression was observed in the glomerular tuft, vascular pole, Bowman's capsule and in discreet areas of interstitial fibrosis ([@R55]). Periostin staining of human renal biopsies appeared to correlate negatively with renal function, supporting a role for periostin in glomerulosclerosis ([@R55]).

It should be noted that 6 different splice variants of periostin, varying in size from 751 to 836 amino acids (83 to 93 kDa) have been identified ([@R26]). These isoforms of periostin are determined by the presence or absence of exons 17--21 due to in-frame alternative splicing. It remains unclear whether the various isoforms have tissue specific expression or unique functions. Since it is possible that the splice variants facilitate diverse effects on the regulation of matrix production, fibrosis, and cell proliferation, understanding the contribution of the various isoforms may be important for designing therapies that target periostin function.

In summary, periostin expression is elevated in the kidneys of *pcy/pcy* mice throughout the progression of cystic disease. Global knockout of *Postn* reduced renal mTOR activity, percentage of proliferating cells, cyst growth, kidney enlargement, interstitial fibrosis and the decline in renal function. Genetic ablation of *Postn* also significantly extended the lifespan of *pcy/pcy* mice. We conclude that aberrant expression of periostin and possibly other matricellular proteins that are expressed during renal development and tissue repair may be important modulators of cystic disease progression.

METHODS {#S9}
=======

Experimental animals and study design {#S10}
-------------------------------------

The *pcy/pcy* mouse phenotype is caused by mutations in *Nphp3*, which is orthologous to human nephronophthisis type 3 ([@R38], [@R56]--[@R58]). Renal cysts form as segmental dilations predominantly in collecting ducts and distal tubules *in utero* and extend to all nephron segments in later stages of the disease ([@R37]). *pcy/pcy* kidneys enlarge to several times normal size and azotemia begins to develop by 18 weeks in association with interstitial fibrosis and progressive decline in renal function, a disease course that is similar to human ADPKD. Generally, *pcy/pcy* mice survive to 30--36 weeks, making this a useful model for investigating the effects of genetic manipulations on disease progression.

*Postn^−/−^* mice were generated by insertion of the β-galactosidase gene into exon 1 of the periostin gene, causing a loss of periostin expression ([@R40]). This homologous recombination strategy removed the DNA encoding for the translation start site, all of first exon and the part of the first intron, replacing it with the bacterial β-galactosidase reporter gene. Newborn and one-week old *Postn^−/−^* mice are indistinguishable from wild-type littermates; whereas, adult mice have mild dwarfism and defects in periosteum, cartilage, cardiac valves and periodontal ligament, tissues that normally express periostin throughout adulthood ([@R40]).

*Postn* knockout in normal CD-1 mice caused a modest reduction in body weight, but had no effect of kidney mass as a percent on total body weight ([Fig. 2a--b](#F2){ref-type="fig"}). We bred *pcy/pcy* mice with *Postn^+/−^* mice to generate *pcy/pcy: Postn^+/−^* mice and these mice were backcrossed into *pcy/pcy* mice (CD-1) for 6--10 generations. In the first group, littermates of *pcy/pcy: Postn^−/−^* and *pcy/pcy: Postn^+/+^* mice were sacrificed at 20 weeks of age, blood was collected for measurement of BUN and then both kidneys were removed causing fatal exsanguinations. The left kidney was homogenized in lysis buffer for protein extraction, and the right kidney was immersed in 4% paraformaldehyde, embedded in paraffin, and sectioned for immunohistochemistry. In the second group of *pcy/pcy* mice, we determined whether periostin expression affected survival by comparing *pcy/pcy: Postn^+/+^, pcy/pcy: Postn^+/−^* and *pcy/pcy: Postn^−/−^* litermates. All animals were provided food and water *ad libitum* and monitored daily. The protocol for use of these mice was approved by the Institutional Animal Care and Use Committee at the University of Kansas Medical Center.

Periostin PCR genotyping {#S11}
------------------------

Genotyping for *Postn* was determined by PCR analysis of genomic DNA with forward (5′-AGTGTGCAGATGTTTGCTTG-3′) and reverse (5′-ACGAAATACAGTTTGGTAATCC-3′) primers to detect the wild-type allele (\~300 bp) and with forward (5′-GCATCGAGCTGGGTAATAAGGGTTGGCAAT-3′) and reverse (5′-GACACCAGACCAACTGGTAATGGTAGCGAC-3′) primers to detect the LacZ in the targeted allele (\~800 bp) ([@R40]).

Quantitative real-time PCR {#S12}
--------------------------

Total RNA was isolated from human ARPKD cells and mouse kidney tissues, loaded onto the column of an RNAeasy Mini Kit and eluted with RNase free water ([@R12]). RNA quality was verified and cDNA was synthesized using Invitrogen SuperScript III first-strand synthesis system. Relative expression levels were determined by SYBR green real-time PCR. Periostin and GAPDH primers were obtained from SuperArray (Frederick, MD).

Measurement of renal cystic area {#S13}
--------------------------------

Tissue sections (5 μm) of paraffin-embedded kidneys from 20-week old *pcy/pcy: Postn^+/+^* and *pcy/pcy: Postn^−/−^* mice were collected 500 μm apart from the largest axial section to avoid redundant measurements of the same cysts. Sections were stained with hematoxylin and eosin and images were collected using a dissecting microscope connected to a digital camera. Total number of cysts and cystic cross-sectional surface area (SA) per kidney section were determined by a blinded observer using a morphometic analysis system.

Measurement of cell proliferation {#S14}
---------------------------------

The number of proliferating cells was determined by staining for PCNA and Ki-67. Briefly, tissue sections were deparaffinized, incubated in 0.3% hydrogen peroxide, rinsed in water and then incubated with an anti-PCNA antibody overnight at 4° C. The antigen was detected using the Zymed SuperPicTure polymer detection kit (Invitrogen) and PCNA-positive cells were visualized using 3,3′-diaminobenzidine. The slides were counter stained with hematoxylin and three images were captured per section for measurement.

Sections were also incubated in anti-Ki-67 antibody (1:100; Abcam, Cambridge, MA) and a secondary anti-rabbit antibody conjugated to AlexaFluor 488 was used to visualize Ki-67 positive nuclei. Nuclei were stained with DAPI in Prolong Gold Antifade mounting reagent (Invitrogen). The number of Ki-67 positive nuclei and total number of nuclei (700--1000 cells/image at 60× magnification) were determined by immunofluorescence using a Nikon Eclipse Ti microscope controlled by Metamorph software.

Measurement of fibrosis {#S15}
-----------------------

Collagen fibers in kidney sections were stained with Masson trichrome and picrosirus red, as described previously ([@R59], [@R60]). Fibrosis (% SA) was determined by a renal pathologist without prior knowledge of the identity of the specimens ([Supplemental Methods](#SD1){ref-type="supplementary-material"}). Collagen fibers are highly birefringent and binding of picrosirius red, which is an elongated dye with anisotropic molecular organization, enhances collagen birefringence. Pathogenic collagen fibers appear as thick brilliant red or yellow bundles against a dark background in polarizing light.

Measurement of Blood Urea Nitrogen {#S16}
----------------------------------

Blood was collected at the time of sacrifice and serum was isolated by centrifugation at 1500 × g for 15 min. BUN was determined using an enzymatic conductivity rate method (Beckman Coulter, Brea, CA).

Western Blot Analysis {#S17}
---------------------

Kidney lysates were prepared for measurements of periostin, phosphorylated S6 (pS6), total S6 and phosphorylated S6K (pS6K) by immunoblot analysis ([@R61]). Proteins (40 μg protein/lane) were separated by 10% SDS-polyacrylamide gel electrophoresis, transferred to nitrocellulose membrane and incubated overnight at 4° C in primary antibody. Membranes were then washed and incubated with secondary antibody conjugated to horseradish peroxidase. Specific antibody signals were detected using chemiluminescence and band images were quantified using a Fluor-S MAX Multi Imager System (Bio-Rad).

Statistics {#S18}
----------

Data are expressed as mean and standard error (SE). Statistical significance was determined by unpaired t-test for comparison between *Postn^+/+^* and *Postn^−/−^* mice.

Supplementary Material {#S21}
======================

Portions of this work have previously been published in abstract form (*J. Am. Soc. Nephrol.* 20: 439A, 2009). The authors thank Dr. Jared Grantham for helpful suggestions during the preparation of the manuscript.
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![Kidney and body weight, and periostin expression in *pcy/pcy* and wildtype mice\
Male *pcy/pcy* mice and wildtype (WT) mice (2--3 mice per group) were sacrificed at 1, 10 and 20 weeks for determination of (**a**) total kidney weight, represented as a percentage of body weight (%BW) and (**b**) body weight. (**c**) Renal periostin (*Postn*) mRNA expression between *pcy/pcy* and WT mice was determined by quantitative real-time RT-PCR. Periostin expression was normalized to GAPDH and the expression in *pcy/pcy* kidneys was represented as fold-change compared to WT kidneys, calculated from Δ C~t~ (N = 3 per group). Data represent mean ± SE. Statistical analysis was determined by ANOVA and SNK post test. \*P \< 0.05. (**d**) Immunoblot for periostin protein (90 kDa) in kidneys of 20-week old *pcy/pcy* and WT mice. Expression of periostin protein was confirmed in two additional pairs of *pcy/pcy* and WT mice ([Supplemental Figure S1](#SD1){ref-type="supplementary-material"}).](nihms537211f1){#F1}

![Effect of periostin expression on kidney weight in *pcy/pcy* mice\
At 20 weeks, body weights of male *pcy/pcy: Postn^+/+^* and *pcy/pcy: Postn^−/−^* mice were measured and kidneys were collected to determine total kidney weight, represented as %BW. **(a)** *Postn^−/−^ (CD-1)* mice had a lower body weight than periostin-expressing littermates consistent with mild dwarfism in mice lacking periostin expression ([@R40]). \*\*P \< 0.001, compared to *Postn^+/+^* mice. (**b**) By contrast, kidney weight (%BW) was not different between *Postn^−/−^* and *Postn^+/+^* mice. **(c)** As expected, *pcy/pcy: Postn^−/−^* mice also had a lower body weight compared to *pcy/pcy: Postn^+/+^* mice. (**d**) There was a 34% reduction in kidney weight (%BW) of *pcy/pcy: Postn^−/−^* mice compared to *pcy/pcy:Postn^+/+^* littermates. Data are means ± SE. Statistical analysis was determined by an unpaired t-test. \*\*P \< 0.001, compared to *pcy/pcy: Postn^+/+^*.](nihms537211f2){#F2}

![Effect of periostin expression on renal cyst development in *pcy/pcy* mice\
**(a)** Representative kidney sections of male *pcy/pcy: Postn^+/+^* and *pcy/pcy: Postn^−/−^* mice. Scale bar is 1 mm. **(b)** Cross-sectional surface area of cysts is represented as % of total area minus the area of the renal pelvis. Data are mean ± SE from three representative sections per kidney. *pcy/pcy: Postn^−/−^* kidneys had a marked reduction in cystic area compared to *pcy/pcy: Postn^+/+^* kidneys. **(c)** The number of cysts (≥ 50 μm) per section was also significantly reduced in the *pcy/pcy: Postn^−/−^* kidneys (190 ± 30 *vs*. 265 ± 15). Data are means ± SE. Statistical analysis was determined by an unpaired t-test. \*P \< 0.05, compared to the *pcy/pcy: Postn^+/+^* kidneys.](nihms537211f3){#F3}

![Effect of periostin on cell proliferation in *pcy/pcy* mice\
Representative kidney sections from **(a)** *pcy/pcy: Postn^+/+^*, **(b)** *pcy/pcy: Postn^−/−^*, **(c)** *Postn^+/+^ (CD-1)*, and **(d)** *Postn^−/−^ (CD-1)* mice were stained with an antibody to proliferating cell nuclear antigen (PCNA), a proliferation marker. All images were taken at the same magnification. Bar scale is 100 μm. The inset in the lower left corner of Fig. 4a shows a higher magnification image of brown-stained nuclei of PCNA-positive cells. Sections were counter stained with hematoxylin. **(e)** The number of PCNA-positive cells per section area (excluding cyst lumens) from three random microscope images was determined by an observer blinded to the identity of the slides. There were significantly fewer PCNA-positive cells in *pcy/pcy* mice lacking periostin, compared to *pcy/pcy:Postn^+/+^* kidneys. **(f)** To further examine the effect of *Postn* deletion on cell proliferation, three tissue sections/kidney (N = 3 kidneys) were stained with an antibody to Ki-67, another proliferation marker. Ki-67 was visualized using a secondary antibody conjugated to GFP and the number of Ki-67 positive cells was quantified by counting GFP-positive cells using a Nikon immunofluorescence microscope controlled by Metamorph software. Total cell numbers were determined by counting nuclei stained with DAPI and data are presented as % of Ki-67 positive cells. There were fewer Ki-67 positive cells in *pcy/pcy: Postn^−/−^* kidney sections compared to the *pcy/pcy: Postn^+/+^* kidney sections, confirming the PCNA results. Data are means ± SE. Statistical analysis was determined by unpaired t-test. \*P \< 0.05, compared to *Postn^+/+^ (CD-1)*; \*\*P \< 0.05 and †P \< 0.001, compared to *pcy/pcy: Postn^+/+^*.](nihms537211f4){#F4}

![Effect of periostin expression on mTOR signaling in *pcy/pcy* mice\
**(a)** Immunoblot analysis was used to compare the effect of *Postn* deletion on phosphorylation levels of the ribosomal protein S6 (pS6), a downstream target of the mTOR signaling pathway, in kidneys of *pcy/pcy* mice. Levels of pS6 were normalized to total S6. The number below the bands indicates the pS6/S6 for each sample. **(b)** Summary of the effect of *Postn* knockout in *pcy/pcy* mice on renal pS6/S6 levels. Data are means ± SE. Statistical analysis was determined by unpaired t-test. \*P \< 0.05, compared to *pcy/pcy: Postn^+/+^* kidney, N = 3.](nihms537211f5){#F5}

![Effect of periostin expression on interstitial collagen deposition in *pcy/pcy* mice\
Representative kidney sections from (**a**) *Postn^+/+^*, (**b**) *Postn^−/−^*, (**c**) *pcy/pcy: Postn^+/+^* and (**d**) *pcy/pcy: Postn^−/−^* mice were stained with Masson trichrome to visualize collagen deposition. There was intense staining of collagen (blue color) within the interstitial areas adjacent cysts in *pcy/pcy* mice expressing *Postn*. By contrast, collagen staining was markedly reduced in cystic areas of *pcy/pcy: Postn^−/−^* mice. All images are the same magnification. Bar scale is 100 μm. (e) Fibrosis was determined by visual assessment of the trichrome-stained slides and represented as % fibrotic area to total area of the whole tissue section. Sections (n = 6 per group) were de-identified and fibrosis was determined by visual measurement of % fibrotic area ([@R62]). Data are means ± SE. Statistical analysis was determined by unpaired t-test. \*P \< 0.05, compared to *pcy/pcy: Postn^+/+^* kidney.](nihms537211f6){#F6}

![Effect of periostin expression on fibrillar collagen in *pcy/pcy* kidneys\
**(a)** Kidney sections of *pcy/pcy: Postn^+/+^* (left) and *pcy/pcy: Postn^−/−^* (right) mice were stained with picrosirius red ([@R59], [@R60]) and illuminated with a polarized light to visualize type I and III collagen fibrils **(b).** Images were digitized with the use of a computer-video analysis system and converted to gray scale for measurement of the area of white pathogenic collagen fibers as a % of total surface area (SA) **(c).** There was a trend for less collagen fibrils in tissue sections of *pcy/pcy: Postn^−/−^* kidneys compared to *pcy/pcy: Postn^+/+^* kidneys; however, the difference did not reach statistical significance (P = 0.06) by an unpaired t-test. Data are means ± SE.](nihms537211f7){#F7}

![Effect of periostin expression on blood urea nitrogen (BUN) in *pcy/pcy* mice\
At 20 weeks, *pcy/pcy: Postn^+/+^* mice had a BUN of 48.7 ± 7.2 mg/dl with five of the six mice with values above 33 mg/dl. The normal range for BUN in healthy adult mice is 8 to 33 mg/dl. By contrast, the mean BUN for *pcy/pcy: Postn^−/−^* mice was 31.3 ± 5.7 mg/dl (P \< 0.05), consistent with improved renal function. Data are means ± SE. Statistical analysis was determined by unpaired t-test.](nihms537211f8){#F8}

![Effect of periostin expression on the lifespan of *pcy/pcy* mice\
The lifespan of *pcy/pcy* mice is 30--36 weeks of age and death is typically caused by renal failure ([@R37]). To determine whether periostin expression affects the survival of *pcy/pcy* mice, littermates of *pcy/pcy: Postn^+/+^*, *pcy/pcy: Postn^+/−^* and *pcy/pcy: Postn^−/−^* mice were given standard diet *ad libitum* until natural death. (**a**) Representative images of kidney sections, kidney weight (KW) as %BW, and % cystic area from *pcy/pcy: Postn^+/+^*, *pcy/pcy: Postn^+/−^* and *pcy/pcy: Postn^−/−^* mice at 20 weeks of age. (**b**) Kaplan-Meier curve of *pcy/pcy: Postn^+/+^*, *pcy/pcy: Postn^+/−^* and *pcy/pcy: Postn^−/−^* mice. (**c**) Summary of the age of death. *pcy/pcy: Postn^+/+^* mice died at 38.1 ± 2.0 weeks. By contrast, *pcy/pcy* mice with the loss of one *Postn* allele (*pcy/pcy: Postn^+/−^*) survived to 44.4 ± 2.4 weeks and *pcy/pcy* mice with a complete loss of periostin expression survived to 51.4 ± 4.2 weeks (\*P \< 0.05, compared to *pcy/pcy: Postn^+/+^*). Data are means ± SE. Statistical analysis was determined by ANOVA and SNK post test.](nihms537211f9){#F9}

###### 

Periostin mRNA levels in recessive models of PKD

                                                          *[N]{.ul}*   [Fold Increase]{.ul}
  ------------------------------------------------------- ------------ ----------------------
  Human ARPKD *vs*. NHK cells                             3            19.6
  *cpk/cpk* mouse kidney *vs*. WT tissue (3 weeks)        3            9.3
  *jck/jck* mouse kidney *vs*. WT tissue (20--25 weeks)   3            \> 50
